Nanomedicine News

RSS

Tek Grup Inks Deal to Distribute MagForce’s NanoTherm Therapy

Tek Grup, a Turkish company distributing medical products, has inked an exclusive distribution deal with MagForce, a medical technology firm focusing on nanomedicine in oncology, to supply MagForce’s NanoTherm therapy in the regions, including Turkey, Azerbaijan, Iraq and Albania.

4 Jun 2012

Nanoparticle-Based Therapeutics Manufacturer Nanocopoeia Launches New Website

Nanocopoeia, Inc., a rapidly-growing nanotechnology company based in St. Paul, has launched its new corporate website, www.nanocopoeia.com.

From Nanocopoeia Inc. 31 May 2012

Researchers Develop New Nanoparticle-Based Drug Technology

For over 30 years, researchers have been trying to use magnetic nanoparticles for drugy delivery. Now, a research team headed by Dr Nial Wheate from the University of Sydney’s Faculty of Pharmacy together with partners in Scotland has developed a technique to magnetically deliver drugs using iron, gold and platinum.

31 May 2012

Researchers Develop New Capsule for Controlled Drug Delivery Using Silica Nanosheets

A research team led by Dr. Qingmin Ji from the Supermolecules Unit of the National Institute for Materials Science’s International Center for Materials Nanoarchitectonics, and Professor Frank Caruso from the University of Melbourne have created an innovative elastic capsule utilizing a flake-shaped inorganic material having a nanometer thickness.

31 May 2012

BBI Exhibits Lateral Flow Diagnostic Technology at BIO Convention 2012

Lateral flow is a flexible and rapid platform for companion diagnostics, offering time, cost and usability efficiencies. This is the message which the BBI Group will be taking to this year’s BIO - June 18th to 21st 2012, Boston.

30 May 2012

Spectrum Pharmaceuticals Starts Phase I Study of Nanotechnology Compound, RenaZorb

Spectrum Pharmaceuticals has started patient enrollment for a Phase I clinical study to assess the tolerability and safety of a lanthanum-based nanotechnology compound named RenaZorb, which has strong phosphate-binding properties.

30 May 2012

DELRUS to Distribute MagForce’s NanoTherm Therapy in Russia and CIS Countries

DELRUS, a major medical device distributor in Russia, has inked a distribution deal with MagForce, a medical technology firm focusing on nanomedicine in oncology, to market MagForce's NanoTherm therapy in the regions, including the Russian Federation, Republic of Uzbekistan, Republic of Tajikistan, Ukraine, Republic of Kazakhstan, Republic of Kyrgyzstan and Belarus Republic.

24 May 2012

Toxicity Study Ensures Safety of Quantum Dots in Nanomedicine Applications

A multi-institute toxicity study on quantum dots in primates has discovered that these nanocrystals are safe for a period of one year.

22 May 2012

Study Findings Help Design Next-Generation Nanocarriers

Researchers believe that atomic-scale design of pharmaceuticals will be instrumental in producing more accurate and efficient drugs. Computer simulations developed by a team headed by Ravi Radhakrishnan from the University of Pennsylvania will be helpful in optimizing these designs.

19 May 2012

New Polymer Allows Improved Method for Preparation of Nanoparticles for Drug Delivery

Ainhoa Lejardi, an engineer at the UPV/EHU, has created a new polymer material which could improve the preparation of nanospheres for their use as a method of controlling the release of pharmaceuticals, research which is currently ongoing at the Spanish National Research Council in Madrid.

18 May 2012